Literature DB >> 8214843

Pharmaceutical representatives and emergency medicine residents: a national survey.

M Reeder1, J Dougherty, L J White.   

Abstract

STUDY
OBJECTIVES: To determine the extent and diversity of involvement of pharmaceutical representatives in emergency medicine residency programs and to assess chief residents' beliefs and attitudes concerning this activity. DESIGN AND PARTICIPANTS: A multi-item survey with cover letter was mailed to the chief resident at each of the 87 Accreditation Council on Graduate Medical Education-approved emergency medicine residency programs in the United States at the time of study conception.
MEASUREMENTS AND MAIN RESULTS: Eighty-three percent (72 of 87) of the questionnaires were returned. Ninety-three percent (66 of 71) of responders reported the involvement of pharmaceutical representatives in their emergency medicine residency. The most frequent activities (90%, 63 of 70) were to distribute small gifts (pens, notepads) and to provide meals during department functions such as journal clubs (80%, 56 of 70). Only 32 of 70 responding chief residents (46%) were aware of any established guidelines in their institution or residency program concerning relationships with pharmaceutical representatives, and 14 respondents (20%) believed that accepting gifts from pharmaceutical companies could affect their own prescribing habits. A few stated that pharmaceutical representative-sponsored educational functions were inappropriate.
CONCLUSION: The interaction of pharmaceutical representatives with emergency medicine residents and residencies is widespread. More than 50% of the institutions supporting emergency medicine residency programs have no formal guidelines with regard to the interaction of their residents with pharmaceutical representatives or their guidelines are not known to the person most responsible for approval and arrangement of the pharmaceutical representative interaction--the emergency medicine chief resident. While most chief residents believed that accepting small gifts was reasonable, they also believed that accepting gifts valued at $100 or more and pharmaceutical representative sponsorship of trips was inappropriate.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health; Professional Patient Relationship; Society for Academic Emergency Medicine

Mesh:

Year:  1993        PMID: 8214843     DOI: 10.1016/s0196-0644(05)81266-1

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  11 in total

Review 1.  Interactions between pharmaceutical representatives and doctors in training. A thematic review.

Authors:  Daniella A Zipkin; Michael A Steinman
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

2.  The Relationship of Industry Payments to Prescribing Behavior: A Study of Degarelix and Denosumab.

Authors:  Jathin Bandari; Robert M Turner; Bruce L Jacobs; David Canes; Ali Moinzadeh; Benjamin J Davies
Journal:  Urol Pract       Date:  2017-01

3.  Teaching trainees to negotiate research collaborations with industry: a mentorship model.

Authors:  David B Merrill; Ragy R Girgis; Lincoln C Bickford; Stanislav R Vorel; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2010-04       Impact factor: 18.112

4.  A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts.

Authors:  R V Gibbons; F J Landry; D L Blouch; D L Jones; F K Williams; C R Lucey; K Kroenke
Journal:  J Gen Intern Med       Date:  1998-03       Impact factor: 5.128

5.  Free drug samples in the United States: characteristics of pediatric recipients and safety concerns.

Authors:  Sarah L Cutrona; Steffie Woolhandler; Karen E Lasser; David H Bor; David U Himmelstein; William H Shrank; Neal S LeLeiko
Journal:  Pediatrics       Date:  2008-10       Impact factor: 7.124

6.  Japanese practicing physicians' relationships with pharmaceutical representatives: a national survey.

Authors:  Sayaka Saito; Kei Mukohara; Seiji Bito
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

7.  Characteristics of recipients of free prescription drug samples: a nationally representative analysis.

Authors:  Sarah L Cutrona; Steffie Woolhandler; Karen E Lasser; David H Bor; Danny McCormick; David U Himmelstein
Journal:  Am J Public Health       Date:  2008-01-02       Impact factor: 9.308

8.  Physicians and drug representatives: exploring the dynamics of the relationship.

Authors:  Susan Chimonas; Troyen A Brennan; David J Rothman
Journal:  J Gen Intern Med       Date:  2007-02       Impact factor: 5.128

9.  A survey of pharmaceutical company representative interactions with doctors in Libya.

Authors:  Mustafa A Alssageer; Stefan R Kowalski
Journal:  Libyan J Med       Date:  2012-09-18       Impact factor: 1.657

Review 10.  Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.

Authors:  Freek Fickweiler; Ward Fickweiler; Ewout Urbach
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.